B-cell chronic lymphocytic leukaemia (CLL) is associated with immunosuppression and
patients are at increased clinical risk following SARS-CoV-2 infection. Covid-19 vaccines …

Simple Summary In chronic lymphocytic leukemia (CLL), immune alterations—affecting both
the innate and adaptive immunity—are very common. As a clinical consequence, patients …

Artificial intelligence (AI), machine learning and predictive modeling are becoming enabling
technologies in many day-to-day applications. Translation of these advances to the patient's …

Chronic lymphocytic leukemia (CLL) is characterized by an expansion of mature B cells in
the bone marrow, peripheral lymphoid organs, and blood. CD4 T helper (Th) lymphocytes …

The relationship between chronic lymphocytic leukaemia (CLL) and qualitative/quantitative
gammaglobulin abnormalities is well established. Nevertheless, in order to better …

Bacterial infections are a major cause of morbidity and mortality in chronic lymphocytic
leukemia (CLL), and infection risk increases in patients treated with the Bruton's tyrosine …

Abstract Chronic Lymphocytic Leukemia (CLL) is well-known for increasing susceptibility to
infections. Factors such as immune dysregulation, IGHV status, hypogammaglobulinemia …

Abstract Objective Immune checkpoint inhibitors (ICIs) have shown promise in
hepatocellular carcinoma (HCC) treatment. With the increasing use of ICIs in cancer …

利妥昔单抗减量的FCR方案一线治疗慢性淋巴细胞白血病疗效分析 Page 1 2022年 临床血液学
杂志 35卷9期 JClinHematol(China) 引用本文:罗菁,张佼佼,张兴利,等.利妥昔单抗减量的FCR方案 …

Causes of death, in particular deaths due to infection, have not been widely studied in
randomised trials in chronic lymphocytic leukaemia. With long-term follow-up (median 13 …